OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the ... OncXerna Therapeutics, Inc.April 10, 2021 GMT Xerna™ TME Panel describes the tumor microenvironment based on dominant biology subtypes with prognostic capabilities in colorectal cancer Data supports the application of Xerna™ TME Panel beyond gastric and ovarian cancers for prospectively-driven trials with OncXerna’s clinical-stage programs WALTHAM, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- OncX...
Source: apnews.com